Background: SH-SY5Y cells exhibit a neuronal phenotype when treated with all-trans retinoic acid (RA), but the molecular mechanism of activation in the signalling pathway mediated by phosphatidylinositol 3-kinase (PI3K) is unclear. To investigate this mechanism, we compared the gene expression profiles in SK-N-SH cells and two subtypes of SH-SY5Y cells (SH-SY5Y-A and SH-SY5Y-E), each of which show a different phenotype during RA-mediated differentiation.
Background
SH-SY5Y cells are the third successive subclone of the SK-N-SH human neuroblastoma cell line [1] . These cells arrest in the G1 phase and exhibit a distinct neuronal phenotype when treated with RA [2] . Morphological changes and expression of biochemical and functional neural markers in SH-SY5Y cells treated with RA resemble those of neurons. SH-SY5Y cells are thus used as a model system for studying the molecular mechanisms involved in neuronal differentiation [3] [4] [5] .
In SH-SY5Y cells, the PI3K/AKT signalling pathway activated by RA is important for the regulation of neuronal survival and differentiation [6] . In addition, RA promotes the activation of PI3K, leading to the activation of a Rho GTPase, RAC1, that is implicated in the activation of MAPKs, expression of neural markers and neurite outgrowth in SH-SY5Y cells [7] . RA treatment of SH-SY5Y cells also induces expression of TRKB (NTRK2), but not of TRKA (NTRK1), and mediates biological responsiveness to receptors for the neurotrophins BDNF and NT-4/5 [8] . Additional treatment of SH-SY5Y cells with BDNF stimulates tyrosine phosphorylation of TRKB [9] , followed by activation of the PI3K/AKT and Ras/MAPK pathways, and the promotion of cell survival and neurite outgrowth in serum-free medium [8, 10] .
Although the activation mechanisms of signalling pathways stimulated by RA and the neurotrophin have been extensively studied, the link between these pathways and the downstream transcriptional network controlling the expression of target genes required for differentiation of SH-SY5Y cells remains unclear. To examine these mechanisms, we compared the gene expression profiles in SK-N-SH cells and two subtypes of SH-SY5Y cells (SH-SY5Y-A and SH-SY5Y-E), each of which display a different morphology during RA-mediated differentiation.
Methods

Cell culture
A protocol including 15% FBS in the culture condition has been previously described [10] as a method for sequential treatment of SH-SY5Y cells with RA and BDNF, although the present study used a D-MEM/F12 1:1 mixture medium, as recommended in the product information sheets. Briefly, random cultured cells from two clone subtypes of SH-SY5Y and SK-N-SH were seeded on laminin-coated culture dishes (BD Bioscience) for 1 day, and were then transferred to medium containing 10 μM RA in the presence or absence of LY294002 (10 μM) for 5 days. For BDNF-induced sequential differentiation of SH-SY5Y-E cells, cells were washed with D-MEM/F12 twice after 5 days and were then incubated with 50 ng/ml BDNF in D-MEM/F12 without serum for 3 days.
Total RNA preparation
For microarray experiments, total cellular RNA was extracted from cells at specific intervals using a RiboPure Kit (Ambion) in accordance with the manufacturer's instructions. The quality of total RNA was assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies). RNA samples were prepared at least twice for each cell line and each time point, were then stored at -80°C.
Oligonucleotide microarray (GeneChip) analysis
Microarray analysis was conducted according to the manufacturer's instructions (Affymetrix) and was performed at least twice in order to confirm the reproducibility of gene expression profiles.
Computational analysis of microarray data
Mean signal intensity for all probes was initially tuned to 500 as global scaling and individual signal intensities were evaluated by a detection call (present/marginal/ absent) using Affymetrix MicroArray Suite 5.0 software (Affymetrix). Absent or marginal detection was judged based on a detected transcript being unreliable or suspicious. Signal intensities for all defective probes meeting this criterion were thus tuned to 100, the average signal intensity of these probes. As most probe sequences were designed for the 3' regions of genes [11] , each signal intensity was normalised using a normalisation factor of 30,000, the signal intensity of the probe (AFFX-HUM-GAPDH/M33197_3_at) derived from the 3' region of GAPDH. All probes on the U133 Plus 2.0 Array were mapped on the human genome (NCBI Build 36.1) with BLAT [12] , and probes with sequences that matched Ref-Seq mapping data [13] were selected. We utilised 29,473 reliable target probes that mapped to their target genes using the Affymetrix formula annotation. Microarray data related to this study are available from the GEO database (accession number: GSE9169) [14] .
Results and discussion
Phenotypic differences between two subtypes of SH-SY5Y
We observed clear differences in the RA-induced neuronal phenotype of the two SH-SY5Y subclones, SH-SY5Y-A and SH-SY5Y-E, which were obtained from two different bioresource centres (ATCC and ECACC, respectively). After 5 days of RA treatment, ECACC (SH-SY5Y-E) cells were slightly larger in size ( Fig. 1A) and contained a significant amount of neuroblastic (N-type) cells and a small fraction of epithelial (S-type) cells (Fig. 1B) . The appearance of S-type cells was suppressed by RA-mediated differentiation on laminin, which promotes neurite outgrowth of SH-SY5Y cells [15] . Full differentiation of RA-treated cells required sequential treatment with BDNF ( Fig. 1C ), thus supporting previous findings [10] . Conversely, ATCC (SH-SY5Y-A) cells easily differentiated into a neuronal phenotype with extended neurites and formed a neural network after 5 days of RA treatment ( Fig. 1E ), again supporting previous observations [16] . The neuronal phenotype of SH-SY5Y-A cells was further enhanced by sequential treatment with RA and BDNF in serum-free medium for 3 days (Fig. 1F ). The original SK-N-SH human neuroblastoma cell line comprises two different cell types: a large fraction of epithelial Schwann cells (S-type cells); and a small number of neuroblast cells (N-type cells) [17] . No neural network is formed by the larger fraction of SK-N-SH cells (> 80%) in the presence of RA ( Fig. 1H ). Instead, these cells elongate and gradually undergo cell death with sequential BDNF treatment under serum-free conditions ( Fig. 1I) .
Identification of expressed genes by using microarray analysis
In order to identify the genes required for progression of neuronal differentiation in RA-treated neuroblastoma cells, we first performed a microarray analysis of global gene expression profiles for the two subtype clones of SH-SY5Y and SK-N-SH cells treated with RA for 5 days. We also included a perturbation experiment using a potent PI3K inhibitor, LY294002, to impair RA-induced differen- tiation of SH-SY5Y cells (data not shown) [6, 7] . For full differentiation of RA-treated SH-SY5Y-E cells, gene expression profiles were also analysed following sequential BDNF treatment of cells for an additional 3 days [10] .
Morphological changes in two subtypes of SH-SY5Y and SK-N-SH under differentiation conditions
We selected 3690 genes (5119 probes) for comparative analysis of gene expression profiles. These genes were extracted by combining 3100 genes (3628 probes) derived from a sum of the top 1000 probes exhibiting significant expression patterns by ANOVA [18, 19] under the 5 culture conditions described above, with 1059 genes (1950 probes) identified as being more significant (Fig.  2 ).
Classification of genes regulated by the PI3K signalling pathway
We first compared the differential gene expression profiles of SH-SY5Y-A cells and SK-N-SH cells, because there is a clear phenotypic difference between these cell lines under RA-treated conditions ( Fig. 1 ). Two-factor ANOVA has previously been used for the statistical analysis of normalised data in order to determine differences in gene expression between cell lines and time points [20] . As summarised in Figure 2 , we identified a gene cluster containing 2517 genes with significantly different expression profiles (p < 0.001) between SH-SY5Y-A cells and SK-N-SH cells treated with RA for 5 days. We also identified 513 genes with expression levels that were significantly downor up-regulated when PI3K was inhibited in RA-treated SH-SY5Y-A cells. Interestingly, 448 of these genes (87.3%) were common in the product sets of gene clusters selected on the basis of differences in expression pattern between SH-SY5Y-A and SK-N-SH. Moreover, expression behaviours of the selected genes were almost identical to those in RA-treated SK-N-SH cells. By removing genes with contradictory profiles or low expression levels, we finally identified gene clusters A and B, comprising 386 genes, and a third "other" cluster with 33 genes regulated by the PI3K signalling pathway in RA-treated SH-SY5Y-A cells. DCX  HMP19  PNMA2  KIF5C  MAP2  SV2C  NEFL  C6orf117  REEP1  ST8SIA2  CRMP1  INA  KIF1A  HAND1  TAGLN3  PTEN  PHF21B  SCG3  GDAP1  ELAVL4  L1CAM  PAK3  RTN1  STMN2  MAPT  SH3PXD2A  SLC8A3  ANK2  GRIK2  CACNA1B  RUFY3  SHANK2  NAPB  ALK  SATB1  SEZ6L  MYT1L  PCDH17  MAP6  SYT13  TPM3  CSPG3  TSPAN2  NEF3  NRXN1  KNS2  PPEF1  NDRG4  FSD1  PRICKLE1  GPR19  CAMK2N1  IGSF4  FOXC1  CNNM2  ANKRD6  AGTPBP1  ROR1  LRP6  CHRFAM7A  CHRNA7  PTPRN2  MAML3  PLD5  MAPK10  ABAT  STXBP1  PPP2R2C  FYN  JAKMIP1  ALDOC  KLF7  OLFM3  TRKB (-FL, -T-Shc)  GRIA3  GNG3  NPTX1  MAP4  SLC30A3  GRIA1  PRKAR2B  BASP1  TUBB2A  DDC  HOOK1  EML4  NEFH  ISL1  SLC38A1  TUBA3  PIK3R3  DLX6  DPYSL5  PRIMA1  FEV  CKB  NRCAM  SHOX2  HTR1E  UCHL1  NBEA  EDG2  DACH1  SNCA  GAP43  ZIC1  D4S234E  KCNH2  BAALC  YWHAG  TUBA6  TUBB3  K-ALPHA-1  ACOT7  SMARCA4  HEY1  TLE1  SLITRK6  ZNF179  LMO3  SEMA6A  TFAP2B  RPH3A  SCG2  SCN3A  FGF11  NCALD  IGSF11  PCDHAC2  PCDHAC1  PCDHA8  PCDHA7  PCDHA6  PCDHA5  PCDHA4  PCDHA3  PCDHA2  PCDHA13  PCDHA12  PCDHA11  PCDHA10  PCDHA1  PCDHA9  SCG5  C5orf13  NGFRAP1  CALCB  NFIA  CRYM  HTR2B  BAI3  MPPED2  TRKB (-T1)  FREM1  PCDH18  CA10  EFNB2  ACCN2   SQLE  PTPRO  ST3GAL6  ACTR3B  C20orf103  ZNF300  RAB33A  ZNF423  CD24  CBS  FAM59B  LMO1  FLJ25076  C6orf159  LOC441061  PRR6  ARNTL  MYCN  ALCAM  LOC201164  HN1  PGM2L1  ENPP2  ANKRD28  NMNAT2  PHACTR3  AFF3  AP3B2  ARL6  PAP2D  ZNF195  ELAVL1  CAMTA1  CXADR  TRIM24  JMJD1C  ESRRG  BCOR  PLEKHA6  BAMBI  TUB  CD200  PLCD4  ZFP37  MLLT11  DKFZP686A01247  MMD  DUSP6  RGS16  ATP6V0A2  PDK1  C3orf32  GPR35  AQP1  C5orf16  C6orf137  TTC9  BCL2  ARHGEF7  TRO  TSHZ3  DPP6  CORIN  CALCA  OSBPL10  XPNPEP1  GNG2  MAGED2  LOC92196  FNDC5  MMP28  UBL3  SCD  HOXD4  SCGN  CCBE1  PRKCH  PGM1  PAPSS1  NEBL  B4GALNT1  CCNA1  ENO3  KIAA1458  SGK  APC  FAM43A  TRIB2  DBC1  STARD4  RGS13  LHFPL2  RAPGEF4  FAM63B  KLHDC8B  PHTF1  ZBED5  FKBP1B  MEIS2  VPS13D  ADD3  C7  ARHGAP28  KIAA0644  FAM13A1  SPRY1  PPFIBP2  FLJ41603  TP53BP1  DKK2  C20orf52  ECH1  MMEL1  HIVEP2  C1orf76  COLEC11  ARMC9  NEK3  MAFB  INSIG1  ARMCX1  WNT3  LOC120376  TSLP  IL20RA  ACAT2  RBMX  DHCR24  UCK2  ZWILCH  METAP2  SFRS2  POP7  OBFC2B  DNMT3A  PLCXD3  ITGA9  RCC2  TBPL1  RPP25  KIAA1509  C1orf19  SEPHS1  BCR  UBE2E1  C1orf36  PIR  SH3TC1  DCN  ASTN2  GPR22  SEPT6  PRSS2  KIAA0125  C1orf106  CNKSR3  LOC283824  CREB3L2 the average signal values of gene expression levels greater than 0.179, the average signal value in the clusters, between RA-treated SK-N-SH cells in the presence and absence of LY294002. In cluster A, the average signal values of 32 of 77 (42%) gene expression levels did not dip below 75% of the average values when RA-treated SK-N-SH cells were exposed to LY294002. Similarly, the average signal values in 35 of 65 (54%) gene expression levels in cluster B did not exceed 125% of the average values by the addition of a PI3K inhibitor (Additional file 1). These findings are consistent with a substantial defect in transcriptional regulation mediated by the PI3K signalling pathway in RA-treated SK-N-SH cells.
Functions Functions
We further categorised genes into two subgroups of neural functions and other functions ( Figs. 3 and 4) , on the basis of Gene Ontology (GO) annotation [21, 22] and a comprehensive search of the literature [22] [23] [24] . Genes with neural functions were defined when significant GO term(s) and/or literal description(s) implicating involvement in neural events were obtained by the gene annotation. We also defined genes with other functions when neither the GO term nor the literal description was related to neural events. GO annotation in two clusters yielded the identification of 114 genes with GO terms related to neural events (Additional File 2). Cluster A genes included 158 genes in the neural function subgroup and 158 genes in the other functions subgroup. Cluster B genes were similarly classified, with 11 genes in the neural function subgroup and 60 genes in the other functions subgroup ( Fig.  3 and 4) . Neural functions were further divided into 9 functions, as summarised in Additional File 2.
Differences in PI3K-mediated transcriptional regulation between two subtypes of SH-SY5Y
To investigate whether the PI3K signalling pathway is sufficiently activated in RA-treated SH-SY5Y-E cells, we further focused on the transcriptional regulation of the 386 genes included in these clusters. Differences in expression profiles of RA-treated SH-SY5Y-E cells with and without LY294002 were compared to differences in expression profiles of RA-treated SH-SY5Y-A cells with and without LY294002 ( Fig. 3 and 4 ). Neurite outgrowth induced in RA-treated SH-SY5Y-E cells was also inhibited by LY294002, thus suggesting that the PI3K signalling pathway is functional in SH-SY5Y-E cells. However, most of the gene expression in the clusters was regulated in a PI3Kindependent manner, and half of the neural genes were expressed at extremely low levels (Figs. 3, 4 and 5A), whereas transcriptional inhibition by LY294002 exclusively emerges after 2-3 days in the presence of RA (Fig.  5A, 5B; bottom panels) . These results suggest that the PI3K signalling pathway is partially disrupted in RAtreated SH-SY5Y-E cells, with this disruption leading to reduced differentiation. These results also suggest that supplementation with an additional TRKB signalling pathway is required for full differentiation of SH-SY5Y-E cells after down-regulation of the gene cluster required for neural events.
Human TRKB is alternatively spliced into at least 3 variants: TRKB-FL; TRKB-T1; and TRKB-T-Shc [25] . TRKB-FL is a tyrosine kinase-containing variant, whereas the intracellular tyrosine kinase domain is truncated in the other proteins [26, 27] . Two typical gene expression profiles were observed by microarray analysis in accordance with different transcriptional regulation on the alternative promoters (Fig. 5B ; bottom panels) [28] . In SH-SY5Y-A cells, TRKB-FL and TRKB-T-Shc variants showed continuously induced transcription over 5 days, whereas gene expression of TRKB-T1 was initially induced but plateaued 1 day after RA treatment. In SH-SY5Y-E cells, expression of all TRKB variants, particularly TRKB-T1, was abruptly induced 3 days after RA treatment and peaked after 5 days in the presence of RA (Fig. 5B; bottom panels) , thus supporting previous results [29] . These TRKB variants were also transcriptionally regulated by the PI3K signalling pathway (Fig. 5B ; bottom panels), indicating clear crosstalk between the TRKB and PI3K signalling pathways. Conversely, induction of TRKB variants was not observed in SK-N-SH cells at any time, providing a possible explanation for the defect in the neuronal phenotype of these cells (Fig. 5B, bottom panels) .
Transcriptional compensation by an additional TRKBmediated signalling pathway in SH-SY5Y-E
Additional BDNF treatment of SH-SY5Y cells stimulates tyrosine phosphorylation of TRKB [9] , promoting neurite outgrowth in serum-free medium [8, 10] . Supporting these findings, additional exposure of RA-treated SH-SY5Y-E cells to BDNF resulted in full differentiation and induced 89 genes that were down-regulated or maintained at low expression levels with RA treatment only (Figs. 5B, 6) . These genes were further sorted into two gene pools: 54 genes from cluster A (shown in blue in Fig.  3; Fig. 6 , left panel) and 35 genes regulated in a PI3K-independent manner (Fig. 6, right panel) . As expected, both of these pools contain many genes required for neural events (Fig. 6 ; Additional File 2), indicating that these genes are critical for TRKB-mediated differentiation of SH-SY5Y-E cells. These results also demonstrate that genes down-regulated either by an impaired PI3K signalling pathway or by another abrogated signalling pathway are transcriptionally compensated for via an additional TRKB-mediated signalling pathway, leading to full differentiation (Additional File 3). However, a significant number of genes down-regulated or maintained at low expression levels in RA-treated SH-SY5Y-E cells did not exceed the threshold (Fig. 6 legend) following additional BDNF treatment ( Fig. 3; Additional File 1) , thus suggesting that the TRKB-dependent signalling pathway only partially compensates for an impaired PI3K signalling pathway. The TRKB variants TRKB-FL and TRKB-T-Shc were induced and plateaued following sequential treatment of SH-SY5Y-E cells with RA and BDNF. Conversely, TRKB-T1 expression, which was strongly induced by RA treatment of SH-SY5Y-E cells, was abruptly down-regulated after a shift to serum-free medium with BDNF (Fig. 5B, bottom  panels) , which supports the notion that the dominantnegative function of tyrosine kinase-deficient receptors [30] is totally diminished by induction of functional TRKB-FL. Further studies may be required to identify the components and transcription factors involved in the TRKB and PI3K signalling pathways.
In conclusion, we identified gene clusters that are transcriptionally controlled by two different signalling pathways mediated by PI3K and TRKB during the differentiation of two subtypes of SH-SY5Y cells. These expression profiling data may prove useful in further elucidating the molecular mechanisms regulating the promoter activities of genes required for neuronal Gene expression profiles during RA-mediated differentiation (continued).
Figure 4
Gene expression profiles during RA-mediated differentiation (continued). Cluster B includes genes that were upregulated by LY294002 in SH-SY5Y-A cells. Cluster "Other" includes 33 genes with contradictory expression profiles between RA-treated SH-SY5Y-A cells with LY294002 and RA-treated SK-N-SH cells. Genes in each cluster were further classified into two subgroups: neural genes; and genes related to other functions. ID1   GAS1  CLU  STAT3  SPP1  APLP2  CRLF1  FLNB   FLNA  IQGAP1  THBS1   TFPI2  KLF6  PLXNA1  TIMP1  VIL2  CD99  SFT2D1  VIM  SEMA3C  RDX  PDLIM1  BCAP29  ANXA2  METRNL  LOC653506  TPM1  FBN1  COL5A1  TMEM166  PRKCSH  H2AFY  CD59  HRH1  PPAPDC1A  TAGLN  DACT1  FN1  CYR61  NARG1  CCL2  GPC6  DOC1  FDXR  RDH10  HIST3H2A  DLC1  LTBP3  C10orf54  SMAD3  TBC1D17  PDCD6IP  CEBPD  ACP6  B3GAT3  HIBADH  NPC2  C1QTNF1  TMEM129  HIST2H2AA3  HIST2H2AA4  SGSH  CFI  PDLIM5  FRMD6  PPIC  IL13RA1  CRTAP  LIFR  KIAA0746 C20orf19  RPS15  RPL13  YPEL3  CG018  CDH11  AMPD3  KIAA1217  ARF3  PGAM1  LOC643576  LOC642969  LDHA  CGI-38  SLC22A18  UBE1L  MAPK12  WARS  C3orf28  MSRB2  HNRPA3  MKI67  CHEK2  MCAM   CHRNA3  SNCAIP  DDIT4  LAMA4  ARHGAP20  IGFBP5  ENO1  CXCL12 A Expression profiles of genes induced by sequential treatment with BDNF in SH-SY5Y-E cells.
Figure 6
Expression profiles of genes induced by sequential treatment with BDNF in SH-SY5Y-E cells. Heat map representation is shown for genes that are down-regulated or maintained at a low level in the presence of RA but are induced by additional treatment with BDNF in SH-SY5Y-E cells. RNA sampling was performed at five time points (0 h, 6 h, 1 day, 2 days and 3 days) after cells were transferred to serum-free medium containing BDNF. To identify the gene expression induced by BDNF, we focused on genes with expression levels that were higher in SH-SY5Y-A cells during differentiation, rather than those in SH-SY5Y-E or SK-N-SH cells. We also selected genes with expression levels in SH-SY5Y-A cells treated with RA for 5 days that exceeded 66.7% of that on day 0, while excluding genes with expression levels that exceeded the 66.7% threshold in SH-SY5Y-E cells treated with RA for 5 days. We selected genes with expression levels that underwent a >1.5-fold change and exceeded the 66.7% threshold when SH-SY5Y-E cells were treated sequentially with BDNF for 3 days. Finally, genes exhibiting similar up-regulation by BDNF in SH-SY5Y-E cells and SK-N-SH cells were also excluded. Genes regulated by the PI3K signalling pathway in RA-treated SH-SY5Y-A cells (left panel) and genes not regulated by the PI3K signalling pathway in SH-SY5Y-A cells (right panel) are shown. The relative alteration of gene expression in these gene pools is summarised in Additional file 1. Genes involved in neural processes are shown in red, and those expressed strongly in brain are shown in purple. Genes encoding transcription factors are underlined. 
